RNA FY 2025 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M+72.1% YoY

Gross Profit

$15M77.9% margin

Operating Income

-$746M-3977.3% margin

Net Income

-$685M-3650.4% margin

EPS (Diluted)

$-4.97

Cash Flow

Operating Cash Flow

-$650M

Free Cash Flow

-$664M

Stock-Based Comp.

$98M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$269M

Stockholders' Equity

$1.7B

Cash & Equivalents

$383M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$11M	+72.1%
Gross Profit	$15M	$11M	+34.0%
Operating Income	-$746M	-$379M	-96.9%
Net Income	-$685M	-$322M	-112.4%